All Stories

  1. Named entity recognition of pharmacokinetic parameters in the scientific literature

    Article • Scientific Reports, October 2024, Springer Science + Business Media

    Dr. José Antonio Cordero

  2. Named Entity Recognition of Pharmacokinetic parameters in the scientific literature

    Article • February 2024, Cold Spring Harbor Laboratory Press

    Dr. José Antonio Cordero

  3. Which is the most common size of the bioequivalence studies around the World

    Article • Pharmacy Education, August 2023, International Pharmaceutical Federation (FIP)

    Dr. José Antonio Cordero

  4. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Article • Cochrane Database of Systematic Reviews, March 2023, Wiley

    Dr. José Antonio Cordero

  5. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain

    Article • F1000Research, April 2022, Faculty of 1000, Ltd.

    Dr. José Antonio Cordero

  6. Prevalence of intermittent hormonal therapy of prostate cancer patients in Spain.

    Article • F1000Research, October 2021, Faculty of 1000, Ltd.

    Dr. José Antonio Cordero

  7. Estimation of intermittent hormonal therapy use in prostate cancer patients of a specific area.

    Article • Pharmacoepidemiology and Drug Safety, March 2019, Wiley

    Dr. José Antonio Cordero

  8. Intermittent Hormonal Therapy in Prostate Cancer patients is also a feasible option.

    Article • Cancer Management and Research, August 2018, Dove Medical Press

    Dr. José Antonio Cordero

  9. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Article • Cochrane Database of Systematic Reviews, November 2014, Wiley

    Dr. José Antonio Cordero

  10. Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers

    Article • Journal of Pharmacy and Pharmacology, April 2004, Wiley

    Dr. José Antonio Cordero

  11. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs

    Article • European Journal of Pharmaceutics and Biopharmaceutics, March 2001, Elsevier

    Dr. José Antonio Cordero

  12. Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency

    Article • Clinical Pharmacology & Therapeutics, November 1999, Springer Science + Business Media

    Dr. José Antonio Cordero

  13. A Comparative Study of the Transdermal Penetration of a Series of Nonsteroidal Antiinflammatory Drugs

    Article • Journal of Pharmaceutical Sciences, April 1997, Elsevier

    Dr. José Antonio Cordero